Holen Sie sich die Stockscreener-App
0.9701
4.89%
-0.0499
Handel nachbörslich:
.97
-0.000100
-0.01%
Schlusskurs vom Vortag:
$1.02
Offen:
$1.02
24-Stunden-Volumen:
170.84K
Relative Volume:
0.70
Marktkapitalisierung:
$43.43M
Einnahmen:
$80.28M
Nettoeinkommen (Verlust:
$-38.83M
KGV:
-1.1663
EPS:
-0.8318
Netto-Cashflow:
$-28.67M
1W Leistung:
-11.00%
1M Leistung:
+70.97%
6M Leistung:
-18.48%
1J Leistung:
-10.18%
1-Tages-Spanne:
$0.9626
$1.06
1-Wochen-Bereich:
$0.95
$1.27
52-Wochen-Spanne:
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.9701 | 45.66M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings - GuruFocus
TELA Q1'26 Earnings: EPS estimate is (0.18) USD - TradingView
TELA Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Why TELA Bio (TELA) could be the turning point you've been waiting for (Moonwalks) 2026-05-08Buy Signals - newser.com
TELA Bio (TELA) shares surge 11% after beating Q4 earnings estimates, defying analyst pessimism.Earnings Risk - newser.com
Earnings Preview: TELA Bio to Report Financial Results Post-market on May 12 - Moomoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat - MyChesCo
TELA Bio (TELA) posts narrower than expected Q4 2025 loss, sending shares up 4.59 percent in today’s trading.Convertible Notes - newser.com
LIQUIFIX offers new approach to mesh fixation, TELA Bio claims - Traders Union
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), TELA Bio (TELA) and Nanobiotix (NBTX) - The Globe and Mail
TELA Bio Reshapes Board, Appoints New Chairman, Directors - The Globe and Mail
What's Driving TELA Bio's Board Refreshment and Strategic Shift - Kavout
Lake Street Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Piper Sandler Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
$19M Q1 tops TELA Bio outlook as 4 new directors join - Stock Titan
TELA Bio Taps Turnaround Titans for Board in Bold Push for Profitability - BriefGlance
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Axos, Gallagher and TELA Bio post strong growth and strategic moves - MSN
TELA Bio: In Unanimous Decision by Current Seven-Member Bd of Directors, Four Directors Agreed to Step Dn Following Annual Meeting June 9 >TELA - Moomoo
[ARS] TELA Bio, Inc. SEC Filing - Stock Titan
TELA Bio (NASDAQ: TELA) outlines 2026 virtual meeting, board refresh and larger equity plan - Stock Titan
Leadership shake-up at TELA Bio (NASDAQ: TELA) as new chair named - Stock Titan
TELA Bio Announces Strategic Board Refreshment with Four - GlobeNewswire
Tela Bio, Inc. Provides Preliminary Revenue for the First Quarter Ended March 31, 2026 - marketscreener.com
TELA Price Today: TELA Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
TELA Bio (TELA) price target decreased by 34.78% to 2.30 - MSN
TELA Bio Schedules Q1 2026 Earnings Release and Call - MyChesCo
TELA Bio (TELA) Gets a Buy from Canaccord Genuity - The Globe and Mail
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
TELA Bio to Announce First Quarter 2026 Financial Results - The Manila Times
TELA Bio plans a May 12 webcast to unpack quarterly results - Stock Titan
TELA Bio launches OviTex Long-Term Resorbable with PLGA reinforcement to advance robotic surgery platforms - Traders Union
TELA Bio (TELA) Stock Bonus Issue (Technical Strength) 2026-04-15High Interest Stocks - UBND thành phố Hải Phòng
TELA Bio urges case-specific approaches for hernia repair at Intuitive Connect - Traders Union
What is the sentiment around TELA Bio (TELA) Stock | Price at $0.59, Down 0.12%Crowd Sentiment Stocks - newser.com
Volume Report: What analysts say about TELA Bio Inc stock2026 Spike Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Aug Levels: What analysts say about TELA Bio Inc stock2026 Key Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Market Wrap: Will TELA Bio Inc benefit from AI trendsM&A Rumor & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Stock Report: Is TELA Bio Inc attractive at current valuation2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Can TELA Bio (TELA) Stock Beat the Market | Price at $0.63, Up 5.47%Stock Community Signals - newser.com
Investment Analysts’ Weekly Ratings Updates for TELA Bio (TELA) - Defense World
TELA Q4 2025 Earnings: TELA Bio Inc. tops EPS views, no revenue logged - Cổng thông tin điện tử tỉnh Lào Cai
TELA Bio unveils new hernia solution with focus on simplicity and reliability - Traders Union
Aug Fed Impact: Is TELA Bio Inc a stock for growth or value investors2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):